Shu‐Ching Chang
Papers
3
Total Citations
25
H-Index
2
About
Shu-Ching Chang is a clinical researcher whose work bridges surgical oncology and evidence-based outcomes, with a focus on improving survival and quality of life for patients with head and neck and urologic cancers. Her key research areas include transoral robotic surgery for HPV-positive oropharyngeal carcinoma and the role of lymph node dissection in prostate cancer management. In a landmark 2020 study, Chang demonstrated that nodal count during transoral robotic surgery and neck dissection is a critical predictor of survival in HPV-positive oropharyngeal cancer—a finding that has shaped surgical standards and garnered 15 citations. She also led a 2021 study showing that cryopreserved placental tissue allograft accelerates time to continence after robot-assisted radical prostatectomy, offering a tangible improvement in postoperative recovery. More recently, Chang has advanced the characterization of lymph node tumor burden in node-positive prostate cancer, exploring how the anatomical compartment and extent of extranodal extension affect biochemical recurrence-free survival. Her work consistently translates complex surgical data into actionable insights, earning her recognition as a contributor to precision oncology and postoperative care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3